|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
180.32/-0.41
|
企业价值
15.79M
|
资产负债 |
每股账面净值
-1.40
|
现金流量 |
现金流量率
--
|
损益表 |
收益
32.20M
|
每股收益
9.94
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
同行比较之报价最少15分钟延迟
业务概览
|
|||
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment. |